3 assets in Mucopolysaccharidosis Type 3

Therapeutic assets addressing Mucopolysaccharidosis Type 3, rated under Floatz methodology v0.2 and sorted by current rating.

Asset	Sponsor	Phase	Rating
Dna (Synthetic Adeno-Associated Virus 9 Vector Scaav9.U1A.Hsgsh Human N-Sulfoglucosamine Sulfohydrolase-Specifying) Mucopolysaccharidosis Type 3	Ultragenyx Pharmaceutical Inc	P2/3	B (59)
Ambroxol Mucopolysaccharidosis Type 3	Ozlem Goker-Alpan	P2/3	B (57)
Duoc-01 Mucopolysaccharidosis Type 3	Joanne Kurtzberg, MD	P1	CC (43)